Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,561 | -26,642 | -42,771 | -34,890 | -17,369 |
| Depreciation Amortization | 155 | 89 | 192 | 122 | 81 |
| Other Working Capital | -3,886 | -2,238 | 3,476 | 1,893 | 1,152 |
| Other Operating Activity | 3,790 | 15,430 | 6,725 | 10,093 | 1,423 |
| Operating Cash Flow | $-27,503 | $-13,362 | $-32,377 | $-22,781 | $-14,713 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -43 | -22 | -864 | -597 | N/A |
| Investing Cash Flow | $-43 | $-22 | $-864 | $-597 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 43,850 | 43,850 | 22,940 | 349 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 22,150 | 0 |
| Financing Cash Flow | $43,850 | $43,850 | $22,940 | $22,499 | $0 |
| Beginning Cash Position | 9,565 | 9,565 | 19,866 | 19,866 | 19,866 |
| End Cash Position | 25,869 | 40,031 | 9,565 | 18,986 | 5,153 |
| Net Cash Flow | $16,304 | $30,466 | $-10,301 | $-880 | $-14,713 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,503 | -13,362 | -32,377 | -22,781 | -14,713 |
| Capital Expenditure | -43 | -22 | -864 | -597 | N/A |
| Free Cash Flow | -27,546 | -13,383 | -33,241 | -23,379 | -14,713 |